Aktis Oncology, Inc. Common stock (AKTS) — Financial Flexibility Index
Aktis Oncology, Inc. Common stock (AKTS) has a Financial Flexibility Index of -0.03x as of December 2024. Free cash flow of $-10.57 Million (operating CF $-12.80 Million minus capex $2.23 Million) represents 0% of total liabilities ($413.98 Million). Check strategic asset allocation of Aktis Oncology, Inc. Common stock to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Aktis Oncology, Inc. Common stock Financial Flexibility Index (2014–2024)
Historical Financial Flexibility Index trend for Aktis Oncology, Inc. Common stock across 21 annual periods. See Aktis Oncology, Inc. Common stock current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Aktis Oncology, Inc. Common stock (2014–2024)
Year-by-year free cash flow to debt coverage for Aktis Oncology, Inc. Common stock. For the full company profile including market capitalisation, see AKTS stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.04x | $17.62 Million | $14.76 Million | $413.98 Million | ▲ +115.7% |
| 2024 | -0.27x | $-34.35 Million | $-40.35 Million | $126.83 Million | ▼ -74.1% |
| 2023 | -0.16x | $-26.24 Million | $-30.00 Million | $168.66 Million | ▲ +70.8% |
| 2023 | -0.53x | $-33.44 Million | $-44.82 Million | $62.68 Million | ▼ -431.3% |
| 2022 | -0.10x | $-15.82 Million | $-18.12 Million | $157.55 Million | ▲ +66.7% |
| 2022 | -0.30x | $-17.48 Million | $-45.20 Million | $57.91 Million | ▲ +0.0% |
| 2021 | -0.30x | $-17.48 Million | $-45.20 Million | $57.91 Million | ▲ +86.4% |
| 2021 | -2.22x | $-16.87 Million | $-29.36 Million | $7.58 Million | ▼ -486.6% |
| 2020 | -0.38x | $-11.35 Million | $-21.30 Million | $29.94 Million | ▲ +0.0% |
| 2020 | -0.38x | $-11.35 Million | $-21.30 Million | $29.94 Million | ▲ +34.5% |
| 2019 | -0.58x | $-12.74 Million | $-17.67 Million | $21.99 Million | ▲ +0.0% |
| 2019 | -0.58x | $-12.74 Million | $-17.67 Million | $21.99 Million | ▼ -24.7% |
| 2018 | -0.46x | $-7.18 Million | $-14.20 Million | $15.46 Million | ▲ +0.0% |
| 2018 | -0.46x | $-7.18 Million | $-14.20 Million | $15.46 Million | ▲ +62.9% |
| 2017 | -1.25x | $-3.86 Million | $-5.55 Million | $3.08 Million | ▲ +0.0% |
| 2017 | -1.25x | $-3.86 Million | $-5.55 Million | $3.08 Million | ▼ -122.2% |
| 2016 | -0.56x | $-1.05 Million | $-1.10 Million | $1.87 Million | ▲ +0.0% |
| 2015 | -0.56x | $-1.05 Million | $-1.10 Million | $1.87 Million | ▲ +78.7% |
| 2015 | -2.65x | $-868.32K | $-980.04K | $327.66K | ▲ +0.0% |
| 2014 | -2.65x | $-868.32K | $-980.04K | $327.66K | ▲ +97.0% |
| 2014 | -88.17x | $-26.98K | $-26.98K | $306.00 | — |